Array biopharma inc

Major-Pharmaceuticals

ARRY


3200 Walnut Street
Boulder , CO 80301

Executive/
Director

Price

  • Last Close
  • $ 6.73
    $ -0.01 -0.15 %
    Jan 3, 2025
  • 52-Week High/Low
  • $26.32 - $6.39
  • YTD
  • 11.2%

  • Trading Volume
  • 187,196
  • Market Cap Full
  • $ 1B
  • Shares Outstanding
  • 151.2M
    Nov 3, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -30.1% 1.7% 27.5% 71.1% -5% -31.5% -28.2% 13.2% -11.3% 11.3%
Q2 20.7% -6.4% 10% 87.7% 4% -47.2% -2.3% 3.3% -27.9% -
Q3 89.6% 47% -8.3% 3.3% 8% 18.7% 50.6% -1.8% -34.9% -
Q4 30.2% 2.8% -6.9% 32.8% 19.7% -15.3% 16.6% -21.4% -9.3% -
J F M A M J J A S O N D
2025 11.3% - - - - - - - - - - -
2024 -21.2% 3% 9.3% -24.3% 25.4% -25% -0.8% -34.9% - - - -10.2%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -11%108%46%11%236%-10%-64%23%-13%-64%11%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -0.11 -0.17 - - (0.23) 0.09
Q2 - - -0.24 - 0.63 0.02 (0.33) 0.34
Q3 - - -0.12 - - (0.22) (0.15) 0.07
Q4 - - -0.05 0.33 0.49 -0.51 -0.15 -
A 0 0 -0.5 0.3 0.5 -0.5 -0.3 0.5

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 127 150.2 150.8
Jun - 127 150.2 150.9
Sep - 127 150.3 151.1
Dec 127 135 150.5 151.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 6.1 3.7 5.7 3.4 -
Fixed Asset Turnover 29.3 23.1 67.2 58.9 -
Total Asset Turnover 1 0.8 1.3 0.7 -
Leverage
Debt Ratio 0.9 0.8 1.1 - -
Debt – Equity Ratio 5.8 -10.3 -5.2 - -
Interest Coverage 0.8 -1 2.6 1.9 -
Equity multiplier 0.5 -0.5 -0.2 - -